Travis C. Mickle

Insider Reports History

Location
2656 Crosspark Road, Suite 100, Coralville, IA
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Travis C. Mickle
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Travis C. Mickle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KEMPHARM, INC President & CEO, Director Common Stock 96.2K $477K $4.96 May 25, 2022 By Mickle Holdings LLC
KEMPHARM, INC President & CEO, Director Common Stock 39.5K $196K $4.96 May 25, 2022 Direct
KEMPHARM, INC President & CEO, Director Common Stock 15.2K $75.6K $4.96 May 25, 2022 By Christal M.M. Mickle 2015 Gift Trust dtd 7/21/15, as trustee
KEMPHARM, INC President & CEO, Director Common Stock 11K $54.7K $4.96 May 25, 2022 By Mickle Investments LLC
KEMPHARM, INC President & CEO, Director Common Stock 9.82K $48.7K $4.96 May 25, 2022 By Travis C. Mickle 2015 Dynasty Trust dtd 7/21/15, Christal M.M. Mickle as trustee
KEMPHARM, INC President & CEO, Director Stock Option (right to buy) 267K Feb 1, 2022 Direct

Insider Reports Filed by Travis C. Mickle

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZVRA KEMPHARM, INC May 25, 2022 3 $57K 4 May 25, 2022 President & CEO, Director
ZVRA KEMPHARM, INC Feb 1, 2022 1 $0 4 Feb 3, 2022 President & CEO, Director
ZVRA KEMPHARM, INC Nov 18, 2021 1 $18.5K 4 Nov 23, 2021 President & CEO, Director
ZVRA KEMPHARM, INC Aug 30, 2021 1 $44.6K 4 Aug 30, 2021 President & CEO, Director
ZVRA KEMPHARM, INC Aug 20, 2021 9 $0 4 Aug 24, 2021 President & CEO, Director
ZVRA KEMPHARM, INC Jun 14, 2021 1 $21.6K 4 Jun 14, 2021 President & CEO, Director